Nebula Research & Development’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $964K | Buy |
3,356
+645
| +24% | +$185K | 0.08% | 411 |
|
2025
Q1 | $836K | Sell |
2,711
-1,873
| -41% | -$577K | 0.08% | 429 |
|
2024
Q4 | $1.62M | Buy |
+4,584
| New | +$1.62M | 0.19% | 159 |
|
2024
Q1 | – | Sell |
-2,997
| Closed | -$659K | – | 1008 |
|
2023
Q4 | $659K | Buy |
2,997
+65
| +2% | +$14.3K | 0.2% | 160 |
|
2023
Q3 | $662K | Buy |
+2,932
| New | +$662K | 0.35% | 75 |
|